Zyprexa Diabetes or Diabetic Ketoacidosis Lawsuits


Zyprexa (olanzapine) is manufactured by Eli Lilly & Co. to treat schizophrenia, bi-polar disorders and some other psychotic mental disorders. Approved by the FDA in 1996, Zyprexa has been prescribed to over 6 million people worldwide. In September of 2003 a possible link between Zyprexa causing diabetes and diabetic ketoacidosis in consumers surfaced.


— No Longer Accepting Cases —

Zyprexa (olanzapine) Information

Zyprexa, also known as olanzapine, is manufactured by Eli Lilly & Co. The drug is used in treating schizophrenia, bi-polar disorders and some other psychotic mental disorders. The Food & Drug Administration (FDA) approved Zyprexa's use as a schizophrenia treatment in 1996 and approved the drug for treatment of bipolar disorder, also known as manic-depressive illness, in 2000. Zyprexa has been prescribed to over 6 million people worldwide since its debut.

Zyprexa News and Additional Information

FDA Requests Eli Lilly & Co. to Change Zyprexa Label

In September 2003, the FDA issued a request to the manufacturer of the very popular antipsychotic medication Zyprexa, used to treat schizophrenia and bipolar disorder, to add a warning to the drug's label of a possible link between Zyprexa and diabetes.

The FDA told doctors that patients using Zyprexa and other "atypical" antipsychotics should be monitored for side effects such as blood-sugar abnormalities, particularly if they have risk factors including obesity and a family history of diabetes, and that "increased attention to the signs and symptoms of diabetes mellitus may lead to earlier detection and appropriate treatment and thus may reduce the risk for the most serious outcomes."

Zyprexa Side Effects

According to medical experts, Zyprexa may be linked to causing diabetes, hyperglycemia (elevated blood sugar levels), and a potentially fatal complication of diabetes called diabetic ketoacidosis in some patients.


— No Longer Accepting Cases —